Animal models used in the screening of antiepileptic drugs

Epilepsia

Volumn 42, Issue SUPPL. 4, 2001, Pages 7-12

  Kupferberg, H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antiepileptic drugs; Antiepileptic screens; Seizure models

Indexed keywords

ANTICONVULSIVE AGENT; PHENOBARBITAL; PHENYTOIN;

ABSENCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; DRUG ACTIVITY; DRUG EFFICACY; DRUG SCREENING; ELECTROGRAPHY; EPILEPTIC STATE; HEREDITY; KINDLING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; VALIDATION PROCESS;

EID: 0034864170     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2001.00002.x     Document Type: Review

References (53)

1. A new series of anticonvulsant drugs tested by experiments on animals
2. Some properties of experimental electroshock seizures
3. Conditions modifying convulsions in animals
4. Comparative assays of antiepileptic drugs in mice and rats
5. The search for new drugs against epilepsy
6. Systemic chemical convulsants and metabolic derangements
7. Central GABA receptor agonists: Comparison of muscimol and baclofen
8. Aminophylline and imidazole as convulsants
9. Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants
10. Strategies for the development of drugs for pharmacoresistant epilepsies
11. Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid
12. Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices
13. Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs: A review
14. Evaluation of anticonvulsant drugs in genetic animal models of epilepsy
15. A review of mouse mutants as genetic models of epilepsy
16. Audiogenic seizures in mice
17. Inherited epilepsy: Spike-wave and focal motor seizures in the mutant mouse tottering
18. Anticonvulsant sensitivity of absence seizures in the tottering mutant mouse
19. Seizure control following administration of anticonvulsant drugs in the quaking mouse
20. El mouse as a model of focal epilepsy: A review
21. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations
22. Anticonvulsant drugs and the genetically epilepsy-prone rat
23. What triggers seizures in the gerbil, Meriones unguiculatus?
24. The gerbil as a model for the study of the epilepsies: Seizure patterns and ontogenesis
25. Induction of seizures by air blast in gerbils: Stimulus duration/effect relationship
26. The genetic animal model of reflex epilepsy in the mongolian gerbil: Differential efficacy of new anticonvulsive drugs and prototype antiepileptics
27. Epileptiform seizures in domestic fowl
28. Anticonvulsants in epileptic fowl
29. Kindling: An animal model of complex partial epilepsy
30. Kindling model of epilepsy
31. Kindling: The first decade
32. Kindling-like effect induced by repeated corneal electroshock in mice
33. Frontal versus transcorneal stimulation to induce maximal electroshock seizures or kindling in mice and rats
34. Validation of corneally kindled mice: A sensitive screening model for partial epilepsy in man
35. Kindling as a model of drug-resistant partial epilepsy: Selection of phenytoin-resistant and nonresistant rats
36. Effects of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) and some antiepileptics on the kindled seizures in the neocortex, hippocampus and amygdala in rats
37. Kindling with rapidly recurring hippocampal seizures
38. Screening and characterization of antiepileptic drugs with rapidly recurring hippocampal seizures in rats
39. A primate model for testing anticonvulsant drugs
40. Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone
41. Only certain antiepileptic drugs prevent seizures induced by pilocarpine
42. Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats
43. Absence epilepsy: Advances in experimental animal models
44. Spontaneous paroxysmal electroclinical patterns in rat: A model of generalized nonconvulsive epilepsy
45. Antiepileptic drug evaluation in a new animal model: Spontaneous petit mal epilepsy in the rat
46. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats
47. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehicles
48. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models
49. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models
50. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices
51. The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. V. Lack of seasonal influences on amygdala kindling in rats
52. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazol seizure thresholds
53. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures